logo-loader
viewReNeuron Group PLC

ReNeuron wins Breakthrough of the Year at 2019 Mediscience Awards

ReNeuron said it looks forward to "continuing to advance our clinical and business development activities in the months ahead".

Reneuron
The group is "greatly encouraged" by the progress it has made

ReNeuron Group PLC (LON:RENE) has won the Breakthrough of the Year award at the 2019 Mediscience Awards in London for the clinical development and commercial progress it has made over the past year.

The developer of stem cell technologies said the award acknowledges positive data from its ongoing phase I/II clinical trial of its hRPC treatment for a rare blindness-causing disease called retinitis pigmentosa.

READ: ReNeuron well funded for pivotal period clinically and commercially

Another recent highlight for the group was the signing of an exclusive licence agreement with Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. for the development, manufacture and commercialisation of ReNeuron's cell therapy programmes in China.

"We are delighted to have been awarded the Breakthrough of the Year award at the 2019 European Mediscience Awards,” said ReNeuron chief executive Olav Hellebø.

“We are greatly encouraged by the progress we have made with our cell therapy clinical development programmes for retinitis pigmentosa and stroke disability over the past year and look forward to continuing to advance our clinical and business development activities in the months ahead."

Quick facts: ReNeuron Group PLC

Price: 134 GBX

LSE:RENE
Market: LSE
Market Cap: £42.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ReNeuron Group PLC named herein, including the promotion by the Company of ReNeuron Group PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Punchy read-through valuation for ADM Energy's Nigerian oil...

Headlines from the Proactive UK newsroom. ADM Energy (LON:ADME) has had a punchy read-through valuation placed on its 5% stake in its field, offshore Nigeria. Petronor has acquired a 12.2% economic interest for US$10mln with a further US$25mln based on future gas production. Reneuron...

3 weeks, 6 days ago

2 min read